The Role of Chemoprevention of Colorectal Cancer with 5-Aminosalicylates in Ulcerative Colitis

被引：13
|
作者：
Herfarth, Hans [1 ]
机构：
[1] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
来源：
DIGESTIVE DISEASES | 2012年 / 30卷
关键词：
Anti-inflammatory agents; Non-steroidal/therapeutic use; Mesalamine; Colorectal cancer; Ulcerative colitis; Crohn's disease; Inflammatory bowel disease; INFLAMMATORY-BOWEL-DISEASE; RISK-FACTORS; RANDOMIZED-TRIAL; NEOPLASIA; MESALAZINE; DYSPLASIA; THERAPY; PREVENT; ACID; ADENOMAS;
D O I：
10.1159/000341894
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5-aminosalicylates (5-ASA) are widely used to treat patients with ulcerative colitis. Experimental data suggest that these agents can potentially be used in a chemopreventive fashion to inhibit the development of colitis-associated colorectal cancer (CRC); however, observational studies investigating a possible risk reduction of CRC by 5-ASA therapy have revealed conflicting results. Currently, it appears that 5-ASA have no or only a very limited effect as a deterrence against CRC. Thus, a general recommendation for long-term use of 5-ASA solely for chemopreventive measures is not warranted. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码：55 / 59
页数：5
相关论文
共 50 条
  • [31] Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer
    Collins, P. D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (12) : 1553 - 1554
  • [32] Impact and risk factors of non-adherence to 5-aminosalicylates in quiescent ulcerative colitis evaluated by an electronic management system
    M. P. Ballester
    D. Marti-Aguado
    M. Fullana
    M. M. Bosca-Watts
    J. Tosca
    E. Romero
    A. Sanchez
    P. Navarro-Cortes
    R. Anton
    F. Mora
    M. Minguez
    International Journal of Colorectal Disease, 2019, 34 : 1053 - 1059
  • [33] Impact and risk factors of non-adherence to 5-aminosalicylates in quiescent ulcerative colitis evaluated by an electronic management system
    Ballester, M. P.
    Marti-Aguado, D.
    Fullana, M.
    Bosca-Watts, M. M.
    Tosca, J.
    Romero, E.
    Sanchez, A.
    Navarro-Cortes, P.
    Anton, R.
    Mora, F.
    Minguez, M.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (06) : 1053 - 1059
  • [34] 5-AMINOSALICYLATES PROMOTE GENERATION OF ANTI-INFLAMMATORY HYDROXY FATTY ACIDS THAT CONTRIBUTE TO INFLAMMATION RESOLUTION IN ULCERATIVE COLITIS
    Wysoczanski, Riccardo
    Kendall, Alexandra C.
    Motwani, Madhur P.
    Vega, Roser
    Rahman, Farooq
    McCartney, Sara
    Bloom, Stuart
    Nicolaou, Anna
    Gilroy, Derek W.
    Segal, Anthony W.
    Marks, Daniel J.
    GASTROENTEROLOGY, 2017, 152 (05) : S996 - S997
  • [35] A Meta-Analysis of the Efficacy of Sulfasalazine in Comparison with 5-Aminosalicylates in the Induction of Improvement and Maintenance of Remission in Patients with Ulcerative Colitis
    Nikfar, Shekoufeh
    Rahimi, Roja
    Rezaie, Ali
    Abdollahi, Mohammad
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (06) : 1157 - 1170
  • [36] Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence
    Bezzio, Cristina
    Festa, Stefano
    Saibeni, Simone
    Papi, Claudio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (04) : 339 - 347
  • [37] 5-Aminosalicylates promote inflammation resolution in ulcerative colitis through generation of anti-inflammatory hydroxy fatty acids
    Wysoczanski, R.
    Kendall, A.
    Motwani, M.
    Vega, R.
    Rahman, F.
    McCartney, S.
    Bloom, S.
    Nicolaou, A.
    Gilroy, D.
    Segal, A.
    Marks, D.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S100 - S101
  • [38] Characterisation of Remission Levels in Patients with Ulcerative Colitis Treated with 5-Aminosalicylates: Results of the CARUC-ASA Prospective Multicentre Study
    Reenaers, C.
    Caenepeel, C.
    Lambrecht, G.
    Pouillon, L.
    Baert, F.
    Cremer, A.
    Colard, A.
    Claessens, C.
    Billiet, T.
    Gedolf, J.
    Strubbe, B.
    Humblet, E.
    de Zutter, A.
    Rahier, J. F.
    Sommers, M.
    Reynders, D.
    Vansteenkiste, L.
    Arijs, I.
    Raeves, A.
    Louis, E.
    Verstockt, B.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1447 - i1447
  • [39] Critical Review of the Evidence on 5-Aminosalicilate for Chemoprevention of Colorectal Cancer in Ulcerative Colitis: A Methodological Question
    Margagnoni, Giovanna
    Pagnini, Cristiano
    Menasci, Francesca
    Festa, Stefano
    Delle Fave, Gianfranco
    CURRENT CLINICAL PHARMACOLOGY, 2014, 9 (01): : 84 - 90
  • [40] Efficacy of Oral,Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis
    Barberio, Brigida
    Segal, Jonathan P.
    Quraishi, M. Nabil
    Black, Christopher J.
    Savarino, Edoardo, V
    Ford, Alexander C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (07): : 1184 - 1196
12345